Patienterne blev randomiseret til enten at få pegyleret interferon alfa 2b (1, 5 µg/ kg/ uge) plus ribavirin (800 mg/ dag) eller Viraferon (3 MIE TIW) plus te
Patients were randomized to receive either pegylated interferon alfa-2b (1.5 µg/ kg/ week) plus ribavirin (800 mg/ day) or Viraferon (3 MIU TIW) rod